Murine typhus, a vector-borne illness transmitted by fleas and caused by Rickettsia typhi, presents significant public health challenges globally. Despite its impact, it often remains underrecognized in health systems. This disease is characterized by non-specific symptoms such as fever, rash, and severe complications in cases involving neurological or multi-organ involvement. The complexity of its clinical presentation frequently leads to misdiagnosis and underreporting, obscuring true transmission dynamics and impeding effective management. Highlighting the need for enhanced diagnostic methods, targeted public health interventions, and increased awareness, this review calls for a strategic focus to better understand and mitigate the influence of murine typhus on global health.
{"title":"Murine typhus: an underappreciated influence on human disease transmission dynamics.","authors":"Parminder Singh, Shubham Kumar, Ashok Kumar Balaraman, Rachana Mehta, Sanjit Sah","doi":"10.1080/23744235.2024.2421906","DOIUrl":"10.1080/23744235.2024.2421906","url":null,"abstract":"<p><p>Murine typhus, a vector-borne illness transmitted by fleas and caused by <i>Rickettsia typhi</i>, presents significant public health challenges globally. Despite its impact, it often remains underrecognized in health systems. This disease is characterized by non-specific symptoms such as fever, rash, and severe complications in cases involving neurological or multi-organ involvement. The complexity of its clinical presentation frequently leads to misdiagnosis and underreporting, obscuring true transmission dynamics and impeding effective management. Highlighting the need for enhanced diagnostic methods, targeted public health interventions, and increased awareness, this review calls for a strategic focus to better understand and mitigate the influence of murine typhus on global health.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"103-105"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142562863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Infectious diseases remain a global health challenge, necessitating innovative approaches for their early diagnosis and effective treatment. Artificial Intelligence (AI) has emerged as a transformative force in healthcare, offering promising solutions to address this challenge. This review article provides a comprehensive overview of the pivotal role AI can play in the early diagnosis and treatment of infectious diseases. It explores how AI-driven diagnostic tools, including machine learning algorithms, deep learning, and image recognition systems, enhance the accuracy and efficiency of disease detection and surveillance. Furthermore, it delves into the potential of AI to predict disease outbreaks, optimise treatment strategies, and personalise interventions based on individual patient data and how AI can be used to gear up the drug discovery and development (D3) process.The ethical considerations, challenges, and limitations associated with the integration of AI in infectious disease management are also examined. By harnessing the capabilities of AI, healthcare systems can significantly improve their preparedness, responsiveness, and outcomes in the battle against infectious diseases.
{"title":"Role of artificial intelligence in early diagnosis and treatment of infectious diseases.","authors":"Vartika Srivastava, Ravinder Kumar, Mohmmad Younus Wani, Keven Robinson, Aijaz Ahmad","doi":"10.1080/23744235.2024.2425712","DOIUrl":"10.1080/23744235.2024.2425712","url":null,"abstract":"<p><p>Infectious diseases remain a global health challenge, necessitating innovative approaches for their early diagnosis and effective treatment. Artificial Intelligence (AI) has emerged as a transformative force in healthcare, offering promising solutions to address this challenge. This review article provides a comprehensive overview of the pivotal role AI can play in the early diagnosis and treatment of infectious diseases. It explores how AI-driven diagnostic tools, including machine learning algorithms, deep learning, and image recognition systems, enhance the accuracy and efficiency of disease detection and surveillance. Furthermore, it delves into the potential of AI to predict disease outbreaks, optimise treatment strategies, and personalise interventions based on individual patient data and how AI can be used to gear up the drug discovery and development (D3) process.The ethical considerations, challenges, and limitations associated with the integration of AI in infectious disease management are also examined. By harnessing the capabilities of AI, healthcare systems can significantly improve their preparedness, responsiveness, and outcomes in the battle against infectious diseases.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"1-26"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142633496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-09-04DOI: 10.1080/23744235.2024.2399101
Emma E Graham, Malte M Tetens, Jacob Bodilsen, Ram Dessau, Svend Ellermann-Eriksen, Nanna S Andersen, Charlotte Sværke Jørgensen, Michael Pedersen, Kirstine K Søgaard, Jette Bangsborg, Alex Christian Nielsen, Jens Kjølseth Møller, Dorrit Obel, Anne-Mette Lebech, Ulrikka Nygaard, Lars H Omland, Niels Obel
Background: Few studies have investigated the risk of psychiatric neurodevelopmental disorders (PNDD) after childhood meningitis.
Methods: Nationwide population-based cohort study (Denmark, 1995-2021) of children with positive cerebrospinal fluid for bacteria or enterovirus, stratified on age as young infants (0 to <90 days, n = 637) or older children (≥90 days to <17 years, n = 1,218). We constructed a comparison cohort from the general population (n = 18,550), and cohorts of siblings of participants. As risk estimates of PNDD we calculated age- and sex-adjusted hazard ratios (aHRs) with 95% confidence intervals (95%CI).
Results: Children with bacterial meningitis had increased risks of PNDD, especially learning and intellectual developmental disorders (young infants: aHR 4.2, 95%CI: 2.4-7.1; older children: aHR 1.5, 95%CI: 1.0-2.3), attention deficit disorder (ADHD) (young infants: aHR 2.8, 95%CI: 1.5-5.2; older children: 1.4, 95%CI: 0.9-2.2) and redemption of ADHD medication (young infants: aHR 2.2, 95%CI: 1.0-4.7; older children: 1.5, 95%CI: 1.0-2.3). Young infants with bacterial meningitis additionally had increased risks of autism spectrum disorders (aHR 1.9, 95%CI: 0.9-4.1) and behavioural and emotional disorders (aHR 2.0, 95%CI: 1.0-3.9). In young infants, the excess risk of PNDD was especially observed in premature children. Siblings of older children with bacterial meningitis also had increased risks of PNDD. Children with enteroviral meningitis at any age did not have increased risks of PNDD or redemption of ADHD medication.
Conclusions: Bacterial meningitis in childhood is associated with subsequent diagnosis of PNDD, while enteroviral meningitis is not. The association appears to be partly explained by prematurity and familial and socioeconomic factors.
{"title":"Risk of psychiatric neurodevelopmental disorders after meningitis in childhood: a nationwide, population-based cohort study.","authors":"Emma E Graham, Malte M Tetens, Jacob Bodilsen, Ram Dessau, Svend Ellermann-Eriksen, Nanna S Andersen, Charlotte Sværke Jørgensen, Michael Pedersen, Kirstine K Søgaard, Jette Bangsborg, Alex Christian Nielsen, Jens Kjølseth Møller, Dorrit Obel, Anne-Mette Lebech, Ulrikka Nygaard, Lars H Omland, Niels Obel","doi":"10.1080/23744235.2024.2399101","DOIUrl":"10.1080/23744235.2024.2399101","url":null,"abstract":"<p><strong>Background: </strong>Few studies have investigated the risk of psychiatric neurodevelopmental disorders (PNDD) after childhood meningitis.</p><p><strong>Methods: </strong>Nationwide population-based cohort study (Denmark, 1995-2021) of children with positive cerebrospinal fluid for bacteria or enterovirus, stratified on age as young infants (0 to <90 days, <i>n</i> = 637) or older children (≥90 days to <17 years, <i>n</i> = 1,218). We constructed a comparison cohort from the general population (<i>n</i> = 18,550), and cohorts of siblings of participants. As risk estimates of PNDD we calculated age- and sex-adjusted hazard ratios (aHRs) with 95% confidence intervals (95%CI).</p><p><strong>Results: </strong>Children with bacterial meningitis had increased risks of PNDD, especially learning and intellectual developmental disorders (young infants: aHR 4.2, 95%CI: 2.4-7.1; older children: aHR 1.5, 95%CI: 1.0-2.3), attention deficit disorder (ADHD) (young infants: aHR 2.8, 95%CI: 1.5-5.2; older children: 1.4, 95%CI: 0.9-2.2) and redemption of ADHD medication (young infants: aHR 2.2, 95%CI: 1.0-4.7; older children: 1.5, 95%CI: 1.0-2.3). Young infants with bacterial meningitis additionally had increased risks of autism spectrum disorders (aHR 1.9, 95%CI: 0.9-4.1) and behavioural and emotional disorders (aHR 2.0, 95%CI: 1.0-3.9). In young infants, the excess risk of PNDD was especially observed in premature children. Siblings of older children with bacterial meningitis also had increased risks of PNDD. Children with enteroviral meningitis at any age did not have increased risks of PNDD or redemption of ADHD medication.</p><p><strong>Conclusions: </strong>Bacterial meningitis in childhood is associated with subsequent diagnosis of PNDD, while enteroviral meningitis is not. The association appears to be partly explained by prematurity and familial and socioeconomic factors.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"89-99"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: HPV-16 infection and viral-host integration are the most important risk factors for cervical cancer (CC). The aim of this study is to develop a new molecular strategy integrated both the viral and host genome variations identifying and monitoring CC.
Method: A total of 312 methylation and 538 RNA-seq datasets were collected from public databases to identify differentially methylated and expressed genes. HPV associated virus integration sites (VISs) were analysed using the ViMIC database. From September 2020 to August 2021, the 70 HPV-16 positive cases retrospectively collected from multi-centre cohorts were subjected to HPV-16 E6 deep sequencing and PCR-based host gene (ASTN1, DLX1, ITGA4, RXFP3, SOX17, ZNF671) methylation detection. RNAseq and expression validation (NNF671) were performed in C-33A cell line harbouring HPV D32E. Lasso and logistic regression algorithm were used to construct the CC diagnostic model.
Results: A positive correlation was observed between the average methylation level of CC patients and their pathological features including tumour stage (p = 0.0077) and HPV subtype (p < 0.001). ZNF671 was identified as a CC-specific methylation marker, with an impressive 93% sensitivity. Both HPV-16 D32E mutation and integration of HPV-16 down-regulated the ZNF671 expression. Finally, a CC diagnostic nomogram was developed by integrating ZNF671 methylation level and HPV E6 mutation feature, yielding an exceptional AUC of 0.997 (95% CI: 0.934-1.000).
Conclusions: Our study demonstrated HPV viral mutations are closely related to host gene epigenetic alterations in CC. Integration of the viral and host genetic information might be a new promising strategy for CC screening.
{"title":"HPV-16 E6 mutation and viral integration related host DNA methylation implicate the development and progression of cervical cancer.","authors":"Chenjun Huang, Xiao Xiao, Wenchao Ai, Honglian Huang, Xuewen Xu, Xiaoyan Zhou, Mengmeng Wang, Zeyu Zhang, Ying Wang, Gao Chunfang","doi":"10.1080/23744235.2024.2391538","DOIUrl":"10.1080/23744235.2024.2391538","url":null,"abstract":"<p><strong>Background: </strong>HPV-16 infection and viral-host integration are the most important risk factors for cervical cancer (CC). The aim of this study is to develop a new molecular strategy integrated both the viral and host genome variations identifying and monitoring CC.</p><p><strong>Method: </strong>A total of 312 methylation and 538 RNA-seq datasets were collected from public databases to identify differentially methylated and expressed genes. HPV associated virus integration sites (VISs) were analysed using the ViMIC database. From September 2020 to August 2021, the 70 HPV-16 positive cases retrospectively collected from multi-centre cohorts were subjected to HPV-16 E6 deep sequencing and PCR-based host gene (ASTN1, DLX1, ITGA4, RXFP3, SOX17, ZNF671) methylation detection. RNAseq and expression validation (NNF671) were performed in C-33A cell line harbouring HPV D32E. Lasso and logistic regression algorithm were used to construct the CC diagnostic model.</p><p><strong>Results: </strong>A positive correlation was observed between the average methylation level of CC patients and their pathological features including tumour stage (<i>p</i> = 0.0077) and HPV subtype (<i>p</i> < 0.001). ZNF671 was identified as a CC-specific methylation marker, with an impressive 93% sensitivity. Both HPV-16 D32E mutation and integration of HPV-16 down-regulated the ZNF671 expression. Finally, a CC diagnostic nomogram was developed by integrating ZNF671 methylation level and HPV E6 mutation feature, yielding an exceptional AUC of 0.997 (95% CI: 0.934-1.000).</p><p><strong>Conclusions: </strong>Our study demonstrated HPV viral mutations are closely related to host gene epigenetic alterations in CC. Integration of the viral and host genetic information might be a new promising strategy for CC screening.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"66-80"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141997034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-08-21DOI: 10.1080/23744235.2024.2389480
Katarina Rosengren, Patrik Gilje, Magnus Rasmussen
Introduction: Infective endocarditis (IE) is a challenging diagnosis to suspect and to confirm. The purpose of this study was to clarify how often IE is suspected already on hospital admission, which clinical signs trigger the physicians' suspicions and to investigate if the empirical treatment is adequate.
Methods: A retrospective observational study of cases with definitive IE, during 2018-2019 in Skåne Region, Sweden was performed. Cases were identified by ICD-codes for IE and medical records were reviewed to reveal if IE was suspected at hospital admission and if empirical treatment was adequate.
Results: Of 156 episodes with definitive IE, suspicion of IE arose on admission in 36 (23%) of the cases. A longer symptom duration, heart murmurs, male sex, and lower age were significantly more common in the group where IE was suspected. In the 118 cases where empirical antibiotic treatment was initiated, 98 (83%) got an adequate empirical treatment while in 16 (14%) of the cases the organism identified was resistant. IE-directed treatment was achieved significantly earlier in the suspicion group, median of 1 day, compared to a median of 2 days (p < 0.0001) when endocarditis was not initially suspected.
Conclusion: IE is suspected already upon admission mainly in cases with a subacute presentation. Increased knowledge of IE with acute presentation could possibly result in earlier diagnosis and correct IE-directed treatment. The clinical impact of this is uncertain since most cases still were treated with adequate empirical antibiotics.
{"title":"Clinical suspicion and empirical treatment of infective endocarditis on hospital admission - a population-based cohort study.","authors":"Katarina Rosengren, Patrik Gilje, Magnus Rasmussen","doi":"10.1080/23744235.2024.2389480","DOIUrl":"10.1080/23744235.2024.2389480","url":null,"abstract":"<p><strong>Introduction: </strong>Infective endocarditis (IE) is a challenging diagnosis to suspect and to confirm. The purpose of this study was to clarify how often IE is suspected already on hospital admission, which clinical signs trigger the physicians' suspicions and to investigate if the empirical treatment is adequate.</p><p><strong>Methods: </strong>A retrospective observational study of cases with definitive IE, during 2018-2019 in Skåne Region, Sweden was performed. Cases were identified by ICD-codes for IE and medical records were reviewed to reveal if IE was suspected at hospital admission and if empirical treatment was adequate.</p><p><strong>Results: </strong>Of 156 episodes with definitive IE, suspicion of IE arose on admission in 36 (23%) of the cases. A longer symptom duration, heart murmurs, male sex, and lower age were significantly more common in the group where IE was suspected. In the 118 cases where empirical antibiotic treatment was initiated, 98 (83%) got an adequate empirical treatment while in 16 (14%) of the cases the organism identified was resistant. IE-directed treatment was achieved significantly earlier in the suspicion group, median of 1 day, compared to a median of 2 days (<i>p</i> < 0.0001) when endocarditis was not initially suspected.</p><p><strong>Conclusion: </strong>IE is suspected already upon admission mainly in cases with a subacute presentation. Increased knowledge of IE with acute presentation could possibly result in earlier diagnosis and correct IE-directed treatment. The clinical impact of this is uncertain since most cases still were treated with adequate empirical antibiotics.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"27-34"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Invasive pneumococcal disease (IPD) remains a significant public health concern, particularly in vulnerable populations such as the elderly. This study focuses on the Faroe Islands, a unique setting for monitoring pneumococcal disease trends due to its high vaccination coverage and geographic isolation.
Objective: To examine the prevalence, trends and serotype distribution of IPD in the Faroe Islands from 2000 to 2023, focusing on the impact of pneumococcal conjugate vaccines (PCVs) on disease incidence and serotype replacement.
Methods: Eighty-six pneumococcal isolates, representing all registered cases of IPD in the Faroe Islands, were analysed during the study period. Data on patient demographics, serotype identification and vaccination history were collected from national health records. Temporal trends in vaccine-type (VT) and non-vaccine-type (nVT) serotypes were analysed, particularly following the introduction of PCV13 in 2010.
Results: Following the introduction of PCV13, a shift from VT to nVT serotypes was observed, while the overall IPD rate remained stable. Notably, there was an increase in IPD cases among the elderly population. The analysis indicated that serotype replacement contributed to a rise in nVT cases despite reducing VT-related IPD.
Conclusions: The findings emphasise the need for ongoing evaluation of pneumococcal vaccine formulations and alternative strategies to address the increasing prevalence of nVT IPD. Higher-valency vaccines and sustained vaccination coverage are critical to mitigating the impact of serotype replacement and improving public health outcomes in the Faroe Islands.
{"title":"A nationwide study of two decades of invasive pneumococcal disease in the Faroe Islands, 2000-2023.","authors":"Arnfinnur Kallsberg, Hans-Christian Slotved, Shahin Gaini, Karen Angeliki Krogfelt","doi":"10.1080/23744235.2024.2440033","DOIUrl":"https://doi.org/10.1080/23744235.2024.2440033","url":null,"abstract":"<p><strong>Background: </strong>Invasive pneumococcal disease (IPD) remains a significant public health concern, particularly in vulnerable populations such as the elderly. This study focuses on the Faroe Islands, a unique setting for monitoring pneumococcal disease trends due to its high vaccination coverage and geographic isolation.</p><p><strong>Objective: </strong>To examine the prevalence, trends and serotype distribution of IPD in the Faroe Islands from 2000 to 2023, focusing on the impact of pneumococcal conjugate vaccines (PCVs) on disease incidence and serotype replacement.</p><p><strong>Methods: </strong>Eighty-six pneumococcal isolates, representing all registered cases of IPD in the Faroe Islands, were analysed during the study period. Data on patient demographics, serotype identification and vaccination history were collected from national health records. Temporal trends in vaccine-type (VT) and non-vaccine-type (nVT) serotypes were analysed, particularly following the introduction of PCV13 in 2010.</p><p><strong>Results: </strong>Following the introduction of PCV13, a shift from VT to nVT serotypes was observed, while the overall IPD rate remained stable. Notably, there was an increase in IPD cases among the elderly population. The analysis indicated that serotype replacement contributed to a rise in nVT cases despite reducing VT-related IPD.</p><p><strong>Conclusions: </strong>The findings emphasise the need for ongoing evaluation of pneumococcal vaccine formulations and alternative strategies to address the increasing prevalence of nVT IPD. Higher-valency vaccines and sustained vaccination coverage are critical to mitigating the impact of serotype replacement and improving public health outcomes in the Faroe Islands.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"1-10"},"PeriodicalIF":0.0,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Environmental contamination with Opisthorchis viverrini eggs significantly impacts on opisthorchiasis transmission and disease control. This study assessed O. viverrini egg contamination in underwater sediments from canals and aimed to reduce O. viverrini transmission in egg-positive and downstream communities by controlling human opisthorchiasis in endemic area of Northeast Thailand.
Methods: Sediment samples from 14 sites in UdonThani municipality were determined for O. viverrini eggs. Human fecal samples and fish were examined for opisthorchiasis and metacercaria infection, respectively. Water samples were analysed for faecal coliforms bacteria. From 2017 to 2023, transmission control efforts were evaluated by monitoring changes in human and fish infection rates.
Results: In 2017 and 2018, O. viverrini eggs were found in canal sediments at 153 and 86 eggs/liter, respectively. Human opisthorchiasis prevalence was 5.3%, with cyprinoid fish showing a 25.0% infection rate (11.6 cysts/infected fish) and significant fecal contamination (>5,500 CFU/100 ml). Conversely, egg-negative sites showed a 0.5% human infection rate and no metacercariae were found. After health interventions (2019 to 2023), O. viverrini eggs were not detected in sediments from canals, resulting in a significant reduction in human opisthorchiasis prevalence to 0.9% at the previously egg-positive site and from 12.2% to 1.7% in downstream communities (p < 0.001). Additionally, the prevalence of metacercariae in cyprinoid fish decreased from 11.4% (7.6 cysts/infected fish) to 4.5% (2.4 cysts/infected fish), indicating reduced transmission.
Conclusion: The presence of O. viverrini eggs in sediment was associated to human opisthorchiasis transmission and demonstrated the significant effectiveness of health interventions in controlling the disease.
{"title":"Environmental contamination of <i>Opisthorchis viverrini</i> eggs and its impact on transmission control in rural northeast Thailand.","authors":"Krissada Namboonrueng, Lakhanawan Charoensuk, Somchai Pinlaor, Umawadee Laothong, Sutas Suttiprapa, Apiporn T Suwannatrai, Suksanti Prakobwong","doi":"10.1080/23744235.2024.2443010","DOIUrl":"https://doi.org/10.1080/23744235.2024.2443010","url":null,"abstract":"<p><strong>Background: </strong>Environmental contamination with <i>Opisthorchis viverrini</i> eggs significantly impacts on opisthorchiasis transmission and disease control. This study assessed <i>O. viverrini</i> egg contamination in underwater sediments from canals and aimed to reduce <i>O. viverrini</i> transmission in egg-positive and downstream communities by controlling human opisthorchiasis in endemic area of Northeast Thailand.</p><p><strong>Methods: </strong>Sediment samples from 14 sites in UdonThani municipality were determined for <i>O. viverrini</i> eggs. Human fecal samples and fish were examined for opisthorchiasis and metacercaria infection, respectively. Water samples were analysed for faecal coliforms bacteria. From 2017 to 2023, transmission control efforts were evaluated by monitoring changes in human and fish infection rates.</p><p><strong>Results: </strong>In 2017 and 2018, <i>O. viverrini</i> eggs were found in canal sediments at 153 and 86 eggs/liter, respectively. Human opisthorchiasis prevalence was 5.3%, with cyprinoid fish showing a 25.0% infection rate (11.6 cysts/infected fish) and significant fecal contamination (>5,500 CFU/100 ml). Conversely, egg-negative sites showed a 0.5% human infection rate and no metacercariae were found. After health interventions (2019 to 2023), <i>O. viverrini</i> eggs were not detected in sediments from canals, resulting in a significant reduction in human opisthorchiasis prevalence to 0.9% at the previously egg-positive site and from 12.2% to 1.7% in downstream communities (<i>p</i> < 0.001). Additionally, the prevalence of metacercariae in cyprinoid fish decreased from 11.4% (7.6 cysts/infected fish) to 4.5% (2.4 cysts/infected fish), indicating reduced transmission.</p><p><strong>Conclusion: </strong>The presence of <i>O. viverrini</i> eggs in sediment was associated to human opisthorchiasis transmission and demonstrated the significant effectiveness of health interventions in controlling the disease.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"1-10"},"PeriodicalIF":0.0,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-17DOI: 10.1080/23744235.2024.2434887
Hugh Watson, Peter Jepsen, Hendrik Vilstrup, Henrik Krarup
Hepatitis delta virus (HDV) infection has an aggressive disease course and is the most difficult to treat of the human hepatitis viruses. In Denmark, as in many countries, the national prevalence of HDV has not been established. Based on diagnoses and laboratory test results in national healthcare registries, we estimated that the prevalence of current HDV infection amongst patients with chronic hepatitis B was 3.1% and the general population prevalence approximately 4 in 100,000.
{"title":"Delta in Denmark: prevalence of hepatitis delta virus infection.","authors":"Hugh Watson, Peter Jepsen, Hendrik Vilstrup, Henrik Krarup","doi":"10.1080/23744235.2024.2434887","DOIUrl":"https://doi.org/10.1080/23744235.2024.2434887","url":null,"abstract":"<p><p>Hepatitis delta virus (HDV) infection has an aggressive disease course and is the most difficult to treat of the human hepatitis viruses. In Denmark, as in many countries, the national prevalence of HDV has not been established. Based on diagnoses and laboratory test results in national healthcare registries, we estimated that the prevalence of current HDV infection amongst patients with chronic hepatitis B was 3.1% and the general population prevalence approximately 4 in 100,000.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142840472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-16DOI: 10.1080/23744235.2024.2441894
Joowon Lee
The pertussis epidemic in Korea is ongoing, with a record-high incidence rate. Although pertussis incidence is high worldwide in 2024, the scale of the increase observed in Korea is unprecedented and incomparable to that in other countries. The high proportion of cases among children aged 5 to 14 years is the distinctive characteristics of the 2024 pertussis epidemic in Korea. To accurately interpret the epidemiological trend in pertussis incidence in Korea, validating the surveillance system and evaluating vaccine efficacy and effectiveness are essential.
{"title":"Pertussis epidemic in Korea and implications for epidemic control.","authors":"Joowon Lee","doi":"10.1080/23744235.2024.2441894","DOIUrl":"https://doi.org/10.1080/23744235.2024.2441894","url":null,"abstract":"<p><p>The pertussis epidemic in Korea is ongoing, with a record-high incidence rate. Although pertussis incidence is high worldwide in 2024, the scale of the increase observed in Korea is unprecedented and incomparable to that in other countries. The high proportion of cases among children aged 5 to 14 years is the distinctive characteristics of the 2024 pertussis epidemic in Korea. To accurately interpret the epidemiological trend in pertussis incidence in Korea, validating the surveillance system and evaluating vaccine efficacy and effectiveness are essential.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142831018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-13DOI: 10.1080/23744235.2024.2438826
Xue Yu, Guo Rao, Yuxin Zhang, Zhaohua Liu, Jun Cai, Xiaoyun Wang, Aixin Yang, Tao He, Guofen Zeng, Jing Liu
Background: Vertebral osteomyelitis (VO) is an infection of the spine with increasing prevalence due to improved diagnostics and aging populations. Multiple pathogens, including Mycobacterium tuberculosis, Brucella spp., and pyogenic bacteria, can cause VO, making differential diagnosis complex, especially in regions with endemic brucellosis and tuberculosis. Early and accurate diagnosis is essential for appropriate treatment.
Methods: This was a single-center, retrospective, observational study performed between 2019 and 2022 in Kashi, Xinjiang.
Results: In this study, a total of 319 patients were enrolled, comprising 45.5% with tuberculous vertebral osteomyelitis (TVO; 52.4% females), 37.9% with brucellar vertebral osteomyelitis (BVO; 19.8% females), and 16.6% with pyogenic vertebral osteomyelitis (PVO; 52.8% females). Demographically, TVO had a longer mean time to diagnosis compared to BVO and PVO. BVO was more prevalent in male, and PVO patients had higher rates of spinal surgery history (45.3%) and diabetes (13.2%). Clinically, TVO patients presented with fever (72.4%), sweating (83.4%), weight loss (71.7%), and appetite loss (84.8%) more frequently, while BVO patients reported more lower back pain (86.0%). Laboratory investigations revealed significantly higher leucocyte and neutrophil levels in PVO, whereas TVO patients had elevated monocyte-to-lymphocyte and platelet-to-lymphocyte ratios. Radiologically, TVO patients exhibited a higher incidence of thoracic involvement (56.6%) and skip lesions (20%). Microbiologically, BVO and PVO had high positive culture rates (84.3 and 84.9%, respectively), with M. tuberculosis isolated from only 4.1% of TVO patients.
Conclusion: These findings underscore the distinct clinical, laboratory, and radiological characteristics of TVO, BVO, and PVO.
{"title":"Vertebral osteomyelitis: a comparative, single-center study in northwestern China.","authors":"Xue Yu, Guo Rao, Yuxin Zhang, Zhaohua Liu, Jun Cai, Xiaoyun Wang, Aixin Yang, Tao He, Guofen Zeng, Jing Liu","doi":"10.1080/23744235.2024.2438826","DOIUrl":"https://doi.org/10.1080/23744235.2024.2438826","url":null,"abstract":"<p><strong>Background: </strong>Vertebral osteomyelitis (VO) is an infection of the spine with increasing prevalence due to improved diagnostics and aging populations. Multiple pathogens, including <i>Mycobacterium tuberculosis</i>, <i>Brucella</i> spp., and pyogenic bacteria, can cause VO, making differential diagnosis complex, especially in regions with endemic brucellosis and tuberculosis. Early and accurate diagnosis is essential for appropriate treatment.</p><p><strong>Methods: </strong>This was a single-center, retrospective, observational study performed between 2019 and 2022 in Kashi, Xinjiang.</p><p><strong>Results: </strong>In this study, a total of 319 patients were enrolled, comprising 45.5% with tuberculous vertebral osteomyelitis (TVO; 52.4% females), 37.9% with brucellar vertebral osteomyelitis (BVO; 19.8% females), and 16.6% with pyogenic vertebral osteomyelitis (PVO; 52.8% females). Demographically, TVO had a longer mean time to diagnosis compared to BVO and PVO. BVO was more prevalent in male, and PVO patients had higher rates of spinal surgery history (45.3%) and diabetes (13.2%). Clinically, TVO patients presented with fever (72.4%), sweating (83.4%), weight loss (71.7%), and appetite loss (84.8%) more frequently, while BVO patients reported more lower back pain (86.0%). Laboratory investigations revealed significantly higher leucocyte and neutrophil levels in PVO, whereas TVO patients had elevated monocyte-to-lymphocyte and platelet-to-lymphocyte ratios. Radiologically, TVO patients exhibited a higher incidence of thoracic involvement (56.6%) and skip lesions (20%). Microbiologically, BVO and PVO had high positive culture rates (84.3 and 84.9%, respectively), with <i>M. tuberculosis</i> isolated from only 4.1% of TVO patients.</p><p><strong>Conclusion: </strong>These findings underscore the distinct clinical, laboratory, and radiological characteristics of TVO, BVO, and PVO.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"1-12"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}